Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients.

Front Pharmacol · 2021 · PMC8669916 · PMID 34916931

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendp = 0.052so close (0.05 < p ≤ 0.1)

CYP3A5 expressor status showed a trend towards association with biopsy-proven acute graft rejection within first week of transplant ( p = 0.052, 95% CI = 0.11–1.01).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.